JP2023053328A5 - - Google Patents

Download PDF

Info

Publication number
JP2023053328A5
JP2023053328A5 JP2023021295A JP2023021295A JP2023053328A5 JP 2023053328 A5 JP2023053328 A5 JP 2023053328A5 JP 2023021295 A JP2023021295 A JP 2023021295A JP 2023021295 A JP2023021295 A JP 2023021295A JP 2023053328 A5 JP2023053328 A5 JP 2023053328A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023021295A
Other languages
English (en)
Japanese (ja)
Other versions
JP7475088B2 (ja
JP2023053328A (ja
Filing date
Publication date
Priority claimed from JP2019560545A external-priority patent/JP7233720B2/ja
Application filed filed Critical
Publication of JP2023053328A publication Critical patent/JP2023053328A/ja
Publication of JP2023053328A5 publication Critical patent/JP2023053328A5/ja
Priority to JP2024062451A priority Critical patent/JP7696658B2/ja
Application granted granted Critical
Publication of JP7475088B2 publication Critical patent/JP7475088B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023021295A 2017-12-24 2023-02-15 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞 Active JP7475088B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024062451A JP7696658B2 (ja) 2017-12-24 2024-04-09 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017247109 2017-12-24
JP2017247109 2017-12-24
JP2019560545A JP7233720B2 (ja) 2017-12-24 2018-12-19 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞
PCT/JP2018/046888 WO2019124468A1 (ja) 2017-12-24 2018-12-19 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019560545A Division JP7233720B2 (ja) 2017-12-24 2018-12-19 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024062451A Division JP7696658B2 (ja) 2017-12-24 2024-04-09 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Publications (3)

Publication Number Publication Date
JP2023053328A JP2023053328A (ja) 2023-04-12
JP2023053328A5 true JP2023053328A5 (cg-RX-API-DMAC7.html) 2023-10-25
JP7475088B2 JP7475088B2 (ja) 2024-04-26

Family

ID=66993541

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019560545A Active JP7233720B2 (ja) 2017-12-24 2018-12-19 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞
JP2023021295A Active JP7475088B2 (ja) 2017-12-24 2023-02-15 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞
JP2024062451A Active JP7696658B2 (ja) 2017-12-24 2024-04-09 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019560545A Active JP7233720B2 (ja) 2017-12-24 2018-12-19 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024062451A Active JP7696658B2 (ja) 2017-12-24 2024-04-09 ヒトメソセリンを特異的に認識する細胞表面分子、il-7、及びccl19を発現する免疫担当細胞

Country Status (20)

Country Link
US (2) US20200323920A1 (cg-RX-API-DMAC7.html)
EP (1) EP3730612B1 (cg-RX-API-DMAC7.html)
JP (3) JP7233720B2 (cg-RX-API-DMAC7.html)
KR (1) KR102830462B1 (cg-RX-API-DMAC7.html)
CN (1) CN111511911B (cg-RX-API-DMAC7.html)
AU (1) AU2018388079B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020012848A2 (cg-RX-API-DMAC7.html)
CA (1) CA3086658A1 (cg-RX-API-DMAC7.html)
DK (1) DK3730612T3 (cg-RX-API-DMAC7.html)
EA (1) EA202091488A1 (cg-RX-API-DMAC7.html)
ES (1) ES3066520T3 (cg-RX-API-DMAC7.html)
FI (1) FI3730612T3 (cg-RX-API-DMAC7.html)
IL (1) IL275453B2 (cg-RX-API-DMAC7.html)
MX (1) MX428412B (cg-RX-API-DMAC7.html)
PL (1) PL3730612T3 (cg-RX-API-DMAC7.html)
PT (1) PT3730612T (cg-RX-API-DMAC7.html)
SA (1) SA520412282B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202005908WA (cg-RX-API-DMAC7.html)
TW (1) TWI811278B (cg-RX-API-DMAC7.html)
WO (1) WO2019124468A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202190624A1 (ru) * 2018-08-31 2021-06-09 Нойл-Иммьюн Байотек, Инк. Car-экспрессирующие т-клетки и car-экспрессирующий вектор
WO2020146902A2 (en) 2019-01-11 2020-07-16 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
IL292542B2 (en) * 2019-10-28 2025-11-01 Noile Immune Biotech Inc Drug for treating cancer, combination drug, drug composition, immune responsive cell, nucleic acid delivery vehicle, and product
CN111235113A (zh) * 2020-01-21 2020-06-05 南京北恒生物科技有限公司 包含嵌合抗原受体的免疫细胞及其用途
KR102309543B1 (ko) 2020-08-04 2021-10-07 주식회사 셀렌진 메소텔린에 특이적으로 결합하는 항-메소텔린 키메릭 항원 수용체
WO2022092841A1 (ko) * 2020-10-28 2022-05-05 주식회사 티에스디라이프사이언스 이종 면역세포에 대한 화학주성을 유도하는 형질전환된 면역세포
CN113380324B (zh) * 2021-05-17 2023-06-27 西安交通大学 一种T细胞受体序列motif组合识别检测方法、存储介质及设备
WO2023009700A2 (en) * 2021-07-29 2023-02-02 Takeda Pharmaceutical Company Limited Car-expressing immune cells that specifically target mesothelin and uses thereof
US20240350627A1 (en) * 2021-07-29 2024-10-24 Takeda Pharmaceutical Company Limited Engineered immune cell that specifically targets mesothelin and uses thereof
CN113651893B (zh) * 2021-08-12 2023-08-01 上海生物制品研究所有限责任公司 联合her2和meso双靶点car-t载体及其构建方法和在癌症中的应用
CN119923410A (zh) 2022-07-28 2025-05-02 莱蒂恩技术公司 用于治疗实体瘤的嵌合抗原受体治疗
US20240261406A1 (en) 2023-02-02 2024-08-08 Minerva Biotechnologies Corporation Chimeric antigen receptor compositions and methods for treating muc1* diseases
WO2025255291A1 (en) * 2024-06-07 2025-12-11 Memorial Sloan-Kettering Cancer Center Chimeric antigen receptors targeting mesothelin and use thereof
WO2026121219A1 (ja) * 2024-12-03 2026-06-11 ノイルイミューン・バイオテック株式会社 遺伝子改変免疫担当細胞の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928287B2 (ja) 1988-09-29 1999-08-03 協和醗酵工業株式会社 新規ポリペプチド
US7795411B2 (en) * 2006-10-05 2010-09-14 Fred Hutchinson Cancer Research Center Vectors for expressing in vivo biotinylated recombinant proteins
KR101559599B1 (ko) * 2007-11-26 2015-10-12 바이엘 인텔렉쳐 프로퍼티 게엠베하 항-메소텔린 항체 및 이의 용도
EP2257572A1 (en) 2008-03-27 2010-12-08 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Human anti-mesothelin monoclonal antibodies
WO2010028795A1 (en) * 2008-09-10 2010-03-18 F. Hoffmann-La Roche Ag Multivalent antibodies
JP5934099B2 (ja) * 2009-10-01 2016-06-15 アメリカ合衆国 抗血管内皮増殖因子受容体−2キメラ抗原受容体及び癌の治療のためのその使用
TWI513466B (zh) * 2010-01-20 2015-12-21 Boehringer Ingelheim Int 抗凝血劑解毒劑
US9272002B2 (en) 2011-10-28 2016-03-01 The Trustees Of The University Of Pennsylvania Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
WO2015188141A2 (en) 2014-06-06 2015-12-10 Memorial Sloan-Kettering Cancer Ceneter Mesothelin-targeted chimeric antigen receptors and uses thereof
RS63601B1 (sr) * 2014-10-09 2022-10-31 Univ Yamaguchi Vektor ekspresije car i t ćelije koje eksprimiraju car
MX2018010974A (es) * 2016-03-17 2019-03-28 Univ Yamaguchi Célula inmunocompetente y vector de expresión que expresa factores reguladores de la función inmune.
CA3019835A1 (en) * 2016-04-08 2017-10-12 Purdue Research Foundation Methods and compositions for car t cell therapy
CA3075886A1 (en) * 2017-10-10 2019-04-18 Yamaguchi University Enhancer for t-cells or b-cells having memory function, malignant tumor recurrence inhibitor, and inducer for inducing memory function in t-cells or b-cells

Similar Documents

Publication Publication Date Title
CN113784732B (zh) 靶向bcma的工程化免疫细胞及其用途
TWI728308B (zh) 一種結合bcma的嵌合抗原受體(car)及其應用
CN113784733B (zh) 靶向bcma的工程化免疫细胞及其用途
JP2023139070A5 (cg-RX-API-DMAC7.html)
JP6420776B2 (ja) 免疫療法のためのエンゲージャー細胞
JP2023514385A (ja) 新規キメラ抗原受容体とその使用
EP4729532A2 (en) Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
WO2019149250A1 (zh) 一种结合bcma的嵌合抗原受体(car)及其应用
KR20230095083A (ko) Cd7 표적의 키메라 항원 수용체 및 이의 용도
JP7404279B2 (ja) 様々な構築物最適化を備えたt細胞抗原カプラ
KR20230066007A (ko) 신규한 보조자극 도메인을 포함하는 키메라 항원 수용체 및 이의 용도
JP2024505955A (ja) 新型キメラ抗原受容体及びその使用
CN110157738B (zh) 靶向cd19和cd22的工程化免疫细胞及其应用
CN108138148A (zh) T细胞的激活和扩增
CN115216449A (zh) 工程化免疫细胞及其用途
WO2018111340A1 (en) Methods for determining potency and proliferative function of chimeric antigen receptor (car)-t cells
JP2024510898A (ja) Ror1を標的とするキメラ抗原受容体
CN117004604A (zh) 一种ciita基因被敲除的工程化免疫细胞及其用途
JP7849891B2 (ja) Ceaを認識するキメラ抗原受容体(car)発現細胞
CN109554349B (zh) Pd-1基因表达沉默的工程化免疫细胞
CN111499766B (zh) 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用
CN115785279A (zh) 包含新型共刺激结构域的嵌合抗原受体及其用途
CN115873801A (zh) 工程化免疫细胞及其用途
CN110540997A (zh) 靶向bcma嵌合抗原受体、核酸序列、载体及应用
CN118525030A (zh) 嵌合抗原受体(car)免疫细胞中的白细胞介素-9信号传导